Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Impella Left Sided Blood Pump Recall Issued Over Risk of Perforations Due to Faulty Instructions FDA indicates that a recent update to the instructions constitutes a Class I recall, since problems with the Impella Blood Pumps can lead to severe injury or death March 25, 2024 Hannah Brown Add Your Comments Abiomed is recalling instructions used for its Impella Left Sided Blood Pumps, due to risk of heart perforation risks, which may have resulted in more than 100 injuries and nearly 50 deaths. The U.S. Food and Drug Administration announced the Impella Left Sided Blood Pump recall correction on March 21, following numerous reports of the pump catheters piercing the wall of the left ventricle in the heart, which may cause serious and life-threatening health effects. Impella Left Sided Blood Pumps are used to keep blood pumping through the heart during percutaneous coronary interventions (PCI). They are also used when a patient has recently undergone a severe heart attack, open-heart surgery, or heart failure doe to cardiomyopathy. As a result of problems with the prior blood pump instructions, the manufacturer reports that there have been at least 129 reports of serious injuries, including 49 reports of death. Impella Heart Pump Lawsuit Did you suffer injuries from an Impella Heart Pump? Lawyers are reviewing Impella Heart Pump lawsuits for individuals who suffered injuries or were fatally injured by a heart pump perforation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Impella Heart Pump Lawsuit Did you suffer injuries from an Impella Heart Pump? Lawyers are reviewing Impella Heart Pump lawsuits for individuals who suffered injuries or were fatally injured by a heart pump perforation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Abiomed Heart Pump Catheter Recall Problems Abiomed initially announced that it was changing the instructions for the Impella 5.5 with Smart Assist in June 2023, following complaints that the pumps may leak purge fluid, resulting in the risk of device failure. Following the initial notice, a device correction was issued, indicating that the instructions for use (IFU) failed to warn doctors to be careful when treating patients who have undergone a TAVR procedure. This means doctors could inadvertently cause the Impella motor housing to come in contact with the implanted heart valves, resulting in damage or destruction of the motor blades. Continuing into August of 2023, Abiomed issued another recall on the Impella pump catheter following at least 12 injuries reported in relation to the catheter system’s instructions and labeling. As a result, the FDA has given the instruction recall a Class I designation, meaning the agency considers problems with the blood pumps to carry a serious risk of injury and death for patients. Abiomed Blood Pump Recall The recall affects approximately 66,390 pumps with the following product names: Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LD. These pumps were distributed nationwide from October 10, 2021, through October 10, 2023. Abiomed issued an Urgent Medical Device Correction Letter on December 27, 2023, warning customers to adhere to the new and revised warnings regarding the pumps. The letter advises customers to carefully position the pump during operative procedures, to use imaging when advancing or torquing the pump catheter, to exercise special care when inserting the catheter or during CPR, to review updated warnings in the device’s instructions for use, to notify everyone at their facility of the corrections, and to notify other facilities where the products have been forwarded. For more information, consumers can contact Abiomed, Inc at 978-646-1400. For any adverse reactions or quality problems consumers can also use the FDA’s MedWatch Adverse Event Reporting program either online, by mail or by fax. Abiomed Impella Heart Pump Lawsuits Given the growing number of undisclosed Impella side effects resulting in serious injuries and fatalities, and new evidence that suggests Abiomed may have known about such risks since January 2018, lawyers are now investigating Impella heart pump lawsuits. Lawsuits are being investigated due to the manufacturer’s potential failure to disclose known adverse events, which could have prevented patients and doctors from making fully informed decisions about the safety of the pumps, potentially leading to additional injuries and deaths. Financial compensation may be available through an Impella heart pump lawsuit for individuals who suffered any of the following complications after receiving the heart pump: Heart tear/perforation Stroke Organ failure Wrongful death Anemia Blood clots Hypertension Bleeding events Prolapsed valve Vascular damage Reduced blood flow Hemolysis (Red blood cell destruction) Other serious injury Tags: Abiomed, Blood Pump, Heart Attack, Heart Failure, Heart Perforations, Impella, Medical Device Recall More Impella Heart Pump Lawsuit Stories Impella Heart Pump Controller Problems May Be Linked to 3 Deaths: FDA July 2, 2025 Impella Pump Lawyers Involved in Class Action Lawsuit To Meet With Judge July 29 June 25, 2025 Impella Pump Class Action Lawsuit Alleges Defects Caused Perforated Left Ventricle, Wrongful Death June 2, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: yesterday) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025) Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: yesterday) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025) Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: 2 days ago) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Impella Pump Class Action Lawsuit Alleges Defects Caused Perforated Left Ventricle, Wrongful Death June 2, 2025
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: yesterday) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)
Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: yesterday) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: 2 days ago) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)